Emil Poulsen

Emil Poulsen is a highly experienced professional in drug substance development and CMC strategy, currently serving as Director at Hemab Therapeutics, where responsibilities include overseeing early-stage development and regulatory support. Previously, Emil held the position of Associate Director CMC at Genmab, focusing on late-stage manufacturing development and control strategy implementation, as well as senior validation roles. Emil's career also includes significant contributions at Biogen in various capacities, where technical leadership was provided for manufacturing sciences, cell culture, and analytical processes. Early career roles included positions at Zymenex and CMC Biologics A/S, specializing in production coordination and upstream process development, respectively. Emil holds a degree in Chemistry and Biotechnology from the Technical University of Denmark and has extensive expertise in fermentation and process optimization from previous roles at Novozymes A/S and Alpharma ApS.